← Open Payments lookup

CALLIE LAND: Open Payments

NPI 1245787365 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,614 in 69 payments from 13 companies in 2025. Trend: 2023 $1,568 · 2024 $1,545 · 2025 $1,614

Food & beverage: $1,503Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$557
ABBVIE INC.10$283
Axsome Therapeutics, Inc.14$205
Teva Pharmaceuticals USA, Inc.6$183
Alkermes, Inc.5$83
Takeda Pharmaceuticals U.S.A., Inc.3$57
Supernus Pharmaceuticals, Inc.3$55
Lundbeck LLC3$45
E.R. Squibb & Sons, L.L.C.2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$30

Products named: INGREZZA, VRAYLAR, Auvelity, ARISTADA, AUSTEDO XR, TRINTELLIX, Qelbree, REXULTI.

Industry payments across TX — which companies pay providers there.